References
- Lue C, van den Wall Blake AW, Prince SJ, Julian BA, Tseng ML, Radl J, Elson CO, Mestecky J. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibidy-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol 1994; 96: 356–363
- Tarkowski A, Lue C, Moldoveanu Z, Kiyono H, McGhee J, Mestecky J. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2–subclass antibody responses. J Immunol 1990; 144: 3770–3778
- Trollmo C, Sollerman C, Carlsten H, Tarkowsky A. The gut as an inductive site for synovial and extra articular immune responses in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 377–382
- Waldman RH, Lazzell VA, Bergman C, Khakoo R, Jacknowictz AI, Howard SA, Rose C. Oral immunization against influenza. Trans Am Clin Climatol Assoc 1982; 93: 133–140
- Waldman RH, Bergman K-C. Oral immunization against respiratory tract pathogens. Allergic et Immunologie 1994; 16: 135–139
- Lue C, Tarkowski A, Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol 1988; 140: 3793–3800
- Kantele A, Arvilommi H, Kantele JM, Rintala L, Mäkelä PH. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi Ty21a vaccines. Microb Pathogen 1991; 10: 117–126
- Pichichero M, Insel R. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. J Allergy Clin Immunol 1983; 72: 481–486
- Peltola H. Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis 1978; 10: 41–44
- Arakere G, Frasch CE. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers. Inf Imm 1991; 59: 4349–4356
- Mäkelä PH, Peltola H, Käyhtu H, Jousimies H, Pettay O, Ruoslahti E, Sivonen A, Renkonen O-V. Polysaccharide vaccines of group A Neisseria meningitis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis 1977; 136: S43–S50, Suppl
- Gotschlich EC, Rey M, Triau R, Sparks KJ. Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest 1972; 51: 89–96
- Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody secreting cells. J Immunol Meth 1983; 57: 301–309
- Käyhty H, Mäkelä O, Eskola J, Saarinen L, Seppälä I. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus Influenzae type b vaccines at 18 to 24 months of age. J Infect Dis 1988; 158: 209–212
- Bienenstock J, Befus AD, McDermot M, Mirski S, Rosenthal K. Regulation of lymphoblast traffic and localization in mucosal tissues with emphasis on IgA. Fed Proc 1983; 42: 3213–3217
- Stroffolini T, Angelini L, Galanti I, Occhionero M, Congiu ME, Mastrantonio P. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carriage state. Microbiologica 1990; 13: 225–229
- Robbins JB. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry 1987; 15: 839–854
- Zangwill KM, Stout D RW, Carlone GM, Pais L, Harekeh H, Mitchell S, Wolfe WH, Blackwood V, Plikaytis BD, Wengner JD. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis 1994; 169: 847–852
- Goldschneider I, Lepow ML, Gotschlich EC, Mauck FT, Bachi F, Randolph M. Immunogenicity of group A and group C meningococcal polysaccharides in infants. J Infect Dis 1973; 128: 769–776